Drawing for NANO-DIAMINO-TETRAC

USPTO serial 86676911

NANO-DIAMINO-TETRAC

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
โ€”
Examiner
SMITH, REBECCA A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NANO-DIAMINO-TETRAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ARLEN L. OLSEN

ARLEN L. OLSEN Schmeiser Olsen & Watts Llp22 Century Hill Dr Ste 302Latham, NY 12110-2137UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical agents and preparations affecting macular degeneration, solid tumors, hematologic malignancies, ocular disorders, angiogenesis, arthritis, dermatology, digestive organs, metabolism, peripheral nervous system, sensory organs, central nervous system, hormonal disorders, diabetes, eye diseases and conditions, heart disorders, joint disease, cancer and the prevention and treatment of cancer, hyperthyroidism, Alzheimer's disease, respiratory diseases, chemotherapy and radioactive in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for use in in vivo diagnostic; appetite suppressants; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based injectable, eye drop or oral delivery tablets or capsules for the continuous release of a wide variety of therapeutic agents; pharmaceutical skin lotion, cream, ointment, and skin patchACTIVEโ€”

Related trademarks

CopyMark links this record to cited ยง2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 19, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 18, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 17, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Jul 16, 2018EX5GSOU EXTENSION 5 GRANTEDโ€”
Jul 16, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGALโ€”
Jul 9, 2018EXT5SOU EXTENSION 5 FILEDโ€”
Jul 9, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 21, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Dec 19, 2017EX4GSOU EXTENSION 4 GRANTEDโ€”
Dec 19, 2017EXT4SOU EXTENSION 4 FILEDโ€”
Dec 19, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Jul 6, 2017EX3GSOU EXTENSION 3 GRANTEDโ€”
Jul 6, 2017EXT3SOU EXTENSION 3 FILEDโ€”
Jul 6, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 5, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Jan 3, 2017EX2GSOU EXTENSION 2 GRANTEDโ€”
Jan 3, 2017EXT2SOU EXTENSION 2 FILEDโ€”
Jan 3, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Jul 6, 2016EX1GSOU EXTENSION 1 GRANTEDโ€”
Jul 6, 2016EXT1SOU EXTENSION 1 FILEDโ€”
Jul 6, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 12, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline โ€” usually six months from the notice date.
Nov 17, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDโ€”
Nov 17, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 28, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDโ€”
Oct 8, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTERโ€”
Oct 7, 2015DOCKASSIGNED TO EXAMINERโ€”
Jul 6, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTEREDโ€”
Jul 2, 2015NWAPNEW APPLICATION ENTEREDโ€”

Frequently asked questions

Related guidance